SRF Q2FY27 Revenue Rises 35% Amid Specialty Chemicals Challenges, Stock Rated Hold
SRF reported a 35% year-on-year revenue increase to INR49 billion in Q2FY27, driven by strong growth in fluorochemicals, performance films, foil, and technical textiles. However, the specialty chemicals segment remained subdued due to pricing pressures, Chinese oversupply, and weak agrochemical demand. EBITDA missed estimates with margin contractions. Management expects specialty chemicals to recover in the second half of FY27 and maintains a 15-20% revenue growth guidance for the chemicals business. Following a recent share price decline, analysts upgraded the stock to Hold with a target price of Rs 2,349.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (49/100). Lens Score 34/100.
Outlets measured: moneycontrol, mint, moneycontrol. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (38–58/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
moneycontrol broke this story on 23 Oct, 04:02 am. Other outlets followed.